Quarterly Transactions Made in T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX). The information is specifically focused on institutions that hold shares of TScan Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q2 2022 | 1,946,503 | 280,485 | 2,226,988 | 9,702 | 1,864,882 | 1,874,584 | 352,404 | |
Q3 2022 | 118,732 | 27,009 | 145,741 | 119,460 | 0 | 119,460 | 26,281 | |
Q4 2022 | 42,782 | 132,186 | 174,968 | 258,208 | 0 | 258,208 | -83,240 | |
Q1 2023 | 145,166 | 556,917 | 702,083 | 7,142 | 0 | 7,142 | 694,941 | |
Q2 2023 | 5,180,185 | 13,728,899 | 18,909,084 | 341,581 | 0 | 341,581 | 18,567,503 | |
Q3 2023 | 1,268,862 | 97,512 | 1,366,374 | 129,762 | 0 | 129,762 | 1,236,612 | |
Q4 2023 | 355,129 | 3,055,249 | 3,410,378 | 152,500 | 0 | 152,500 | 3,257,878 | |
Q1 2024 | 1,619,715 | 1,019,850 | 2,639,565 | 97,376 | 0 | 97,376 | 2,542,189 | |
Q2 2024 | 5,204,011 | 9,019,360 | 14,223,371 | 1,524,281 | 0 | 1,524,281 | 12,699,090 | |
Q3 2024 | 1,524,458 | 6,369,574 | 7,894,032 | 1,433,515 | 10,792 | 1,444,307 | 6,449,725 | |
Q4 2024 | 2,327,535 | 560,633 | 2,888,168 | 1,284,347 | 0 | 1,284,347 | 1,603,821 | |
Q1 2025 | 3,529,213 | 605,265 | 4,134,478 | 4,779,646 | 0 | 4,779,646 | -645,168 | |
Q2 2025 | 465 | 0 | 465 | — | 465 |